Ajanta Pharma has been awarded from Fortune India on various parameters as the company has ranked 3rd largest Wealth Creator on 5 year CAGR 93.14% in Mid Size companies and it ranked 10th on Return on Capital Employed (ROCE). The company has also ranked 21st in Net Profit and ranked 182nd in Sales.
Fortune India has published list of 500 mid-size companies and ranked them on various parameters based on the results of 2013-14.
Ajanta Pharma is a leading speciality generic company with clear focus on fast growing therapeutic segments of Cardiology, Opthalmology, Dermatology, Anti-malarials & Pain Management and is among the fastest growing in the country. Many of company’s products are first in the market place and are leading in their sub therapeutic segments.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: